Topical Medication Therapy for Glaucoma and Ocular Hypertension
Glaucoma is one of the most common causes of blindness, thus seriously affecting people’s health and quality of life. The topical medical therapy is as the first line treatment in the management of glaucoma since it is inexpensive, convenient, effective, and safe. This review summarizes and compares...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a431718bd274d4cab37383978bd6879 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9a431718bd274d4cab37383978bd6879 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9a431718bd274d4cab37383978bd68792021-12-02T00:04:32ZTopical Medication Therapy for Glaucoma and Ocular Hypertension1663-981210.3389/fphar.2021.749858https://doaj.org/article/9a431718bd274d4cab37383978bd68792021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.749858/fullhttps://doaj.org/toc/1663-9812Glaucoma is one of the most common causes of blindness, thus seriously affecting people’s health and quality of life. The topical medical therapy is as the first line treatment in the management of glaucoma since it is inexpensive, convenient, effective, and safe. This review summarizes and compares extensive clinical trials on the topical medications for the treatment of glaucoma, including topical monotherapy agents, topical fixed-combination agents, topical non-fixed combination agents, and their composition, mechanism of action, efficacy, and adverse effects, which will provide reference for optimal choice of clinical medication. Fixed-combination therapeutics offer greater efficacy, reliable security, clinical compliance, and tolerance than non-fixed combination agents and monotherapy agents, which will become a prefer option for the treatment of glaucoma. Meanwhile, we also discuss new trends in the field of new fixed combinations of medications, which may better control IOP and treat glaucoma.Tao WangLinlin CaoQikun JiangTianhong ZhangFrontiers Media S.A.articleglaucomamonotherapyfixed combination therapynon-fixed combination therapyintraocular pressureadverse effectsTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
glaucoma monotherapy fixed combination therapy non-fixed combination therapy intraocular pressure adverse effects Therapeutics. Pharmacology RM1-950 |
spellingShingle |
glaucoma monotherapy fixed combination therapy non-fixed combination therapy intraocular pressure adverse effects Therapeutics. Pharmacology RM1-950 Tao Wang Linlin Cao Qikun Jiang Tianhong Zhang Topical Medication Therapy for Glaucoma and Ocular Hypertension |
description |
Glaucoma is one of the most common causes of blindness, thus seriously affecting people’s health and quality of life. The topical medical therapy is as the first line treatment in the management of glaucoma since it is inexpensive, convenient, effective, and safe. This review summarizes and compares extensive clinical trials on the topical medications for the treatment of glaucoma, including topical monotherapy agents, topical fixed-combination agents, topical non-fixed combination agents, and their composition, mechanism of action, efficacy, and adverse effects, which will provide reference for optimal choice of clinical medication. Fixed-combination therapeutics offer greater efficacy, reliable security, clinical compliance, and tolerance than non-fixed combination agents and monotherapy agents, which will become a prefer option for the treatment of glaucoma. Meanwhile, we also discuss new trends in the field of new fixed combinations of medications, which may better control IOP and treat glaucoma. |
format |
article |
author |
Tao Wang Linlin Cao Qikun Jiang Tianhong Zhang |
author_facet |
Tao Wang Linlin Cao Qikun Jiang Tianhong Zhang |
author_sort |
Tao Wang |
title |
Topical Medication Therapy for Glaucoma and Ocular Hypertension |
title_short |
Topical Medication Therapy for Glaucoma and Ocular Hypertension |
title_full |
Topical Medication Therapy for Glaucoma and Ocular Hypertension |
title_fullStr |
Topical Medication Therapy for Glaucoma and Ocular Hypertension |
title_full_unstemmed |
Topical Medication Therapy for Glaucoma and Ocular Hypertension |
title_sort |
topical medication therapy for glaucoma and ocular hypertension |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/9a431718bd274d4cab37383978bd6879 |
work_keys_str_mv |
AT taowang topicalmedicationtherapyforglaucomaandocularhypertension AT linlincao topicalmedicationtherapyforglaucomaandocularhypertension AT qikunjiang topicalmedicationtherapyforglaucomaandocularhypertension AT tianhongzhang topicalmedicationtherapyforglaucomaandocularhypertension |
_version_ |
1718403943797620736 |